MK 2866 25mg

MK-2866 (25mg) is a specialized research reagent utilized primarily to investigate the biochemical pathways of selective androgen receptor modulation and the regulation of musculoskeletal protein synthesis. As a potent, non-steroidal Selective Androgen Receptor Modulator (SARM), it is a fundamental tool for exploring tissue-specific anabolic signaling while minimizing androgenic activity in non-target tissues. Dragon Pharma provides MK-2866 (Ostarine) at a purity level of 99%+, specifically for use in in-vitro laboratory experiments and preclinical animal models.

Overview

In the realm of musculoskeletal biology and endocrine research, MK-2866 has become a primary instrument for investigators exploring the androgen signaling axis. Known scientifically as Enobosarm or Ostarine, this compound offers high affinity and selectivity for the androgen receptor (AR), allowing for the study of muscle hypertrophy and bone mineralization without the systemic complications associated with traditional steroidal ligands. Dragon Pharma provides MK-2866 25mg at a minimum purity of 99%, ensuring that researchers have access to a high-grade Research Compound capable of producing reproducible and accurate data in complex biological models.

As scientific inquiry into sarcopenia, cancer-induced cachexia, and metabolic bone health expands, the need for reliable SARMs like MK-2866 has grown. This expanded profile examines the biochemical characteristics, structural integrity, and multifaceted research applications of MK-2866 25mg.

Molecular Characteristics and Chemical Profile

The structural integrity of MK-2866 is what allows it to bind to the androgen receptor with high specificity. Unlike traditional androgens, it lacks the steroid nucleus, which prevents its conversion into estrogen via aromatase or dihydrotestosterone via 5$\alpha$-reductase.

• Chemical Identity: MK-2866 (Ostarine/Enobosarm)
• Molecular Formula: $C_{19}H_{14}F_{3}N_{3}O_{3}$
• Molecular Weight: 389.33 g/mol
• Purity: >99% (HPLC and Mass Spectrometry verified)
• Form: Crystalline powder / Lyophilized powder
• Manufacturer: Dragon Pharma

s

Research Applications

The compound is utilized in various scientific investigative domains, including:

• Androgen Receptor Kinetics: Mapping the binding affinity ($K_{i}$) and transcriptional co-activator recruitment.
• Skeletal Muscle Hypertrophy: Investigating the modulation of myofibrillar protein synthesis and satellite cell activation.
• Osteoblastic Activity: Studying the enhancement of bone mineral density and the prevention of osteopenia.
• Metabolic Rate Regulation: Assessing the impact of AR activation on basal metabolic rate and lipid oxidation.
• Tissue Selectivity Models: Evaluating the anabolic-to-androgenic ratio compared to dihydrotestosterone or testosterone propionate.

Pathway and Mechanistic Context

The core value of MK-2866 25mg in a laboratory setting is its ability to manipulate the Anabolic Transcriptional Program without altering the initial synthesis of endogenous hormones. In a natural physiological state, the androgen receptor regulates the maintenance of lean tissue and bone mass.

The Selective Androgen Receptor Axis

Upon binding to the AR by MK-2866, the receptor-ligand complex translocates to the nucleus. This initiates a global shift in cellular behavior, promoting the activation of protein synthesis pathways (such as the mTOR pathway) and the suppression of catabolic genes.

Key Mechanistic Shifts:

• Nitrogen Retention Potentiation: MK-2866 facilitates the maintenance of a positive nitrogen balance, providing a framework for studying the reversal of muscle-wasting states.
• Myostatin Modulation: It influences the expression of myostatin and other growth-limiting factors, useful for research into advanced muscular dystrophy.
• Selective Recruitment: Researchers use MK-2866 to observe how the ligand-receptor complex interacts with tissue-specific co-regulators, leading to anabolic effects in muscle while remaining neutral in prostatic tissue

Primary Research Applications

1. Sarcopenia and Geriatric Research

MK-2866 is heavily utilized in studies involving age-related muscle loss. Statistics indicate that sarcopenia affects approximately 10% of adults over age 60, with prevalence increasing to 50% in those over age 80. Research shows that muscle loss can vary by group; in certain U.S. clinical models, Non-Hispanic Black men were found to have a lower prevalence of sarcopenia (7.1%) compared to Non-Hispanic White men (11.4%) and Hispanic men (12.8%), often due to higher baseline muscle mass. MK-2866 provides a unique framework for investigating the restoration of functional strength in these varied models.

2. Cancer-Induced Cachexia

Known in research circles for its "anti-wasting" potential, MK-2866 is used to observe how tissues adapt to the extreme metabolic stress of oncology models. In Phase II clinical trials, subjects with cancer-related wasting showed a significant increase in lean body mass, with a mean increase of 1.5 kg (3.3 lbs) over 113 days compared to a placebo group that lost weight.

3. Metabolic Dysfunction and Diabetes

In metabolic research, MK-2866 is studied for its ability to improve insulin sensitivity. Research models focus on how AR modulation can mitigate the damage caused by chronic inactivity; clinical data has shown that MK-2866 can reduce fasting blood glucose by up to 15 mg/dL and improve insulin resistance markers.

Form and Analytical Testing

At Dragon Pharma, the commitment to scientific accuracy begins with a rigorous manufacturing process. MK-2866 25mg is produced under strict laboratory conditions to ensure the compound remains stable and potent.

• Stability and Purity: The compound is optimized for long-term stability, removing impurities that could interfere with sensitive hormonal or metabolic assays.
• Rigorous Analytical Verification: To guarantee a purity level of 99% or higher, every batch undergoes High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to confirm that the chemical signature matches the verified Ostarine profile.